Skip to content
Inciteful Med

The Major Subtypes: Fuchs, Lattice, Granular, and Macular

Last updated:

Corneal dystrophy is a group of eye conditions. Your specific subtype—Fuchs, Lattice, Granular, or Macular—determines your exact symptoms, when vision loss begins, and what kind of corneal transplant you may need. Knowing your exact diagnosis is the most important factor in your care.

Key Takeaways

  • • Fuchs dystrophy affects the inner layer of the cornea, causing morning blurriness and swelling that usually appears after age 40.
  • • Lattice dystrophy can cause painful recurrent corneal erosions (eye scratches) starting as early as the teenage years.
  • • Macular dystrophy is often more severe, starting in childhood and requiring both parents to pass down the mutated gene.
  • • Your specific subtype dictates whether you will need a partial-thickness or full-thickness corneal transplant if surgery becomes necessary.

While “corneal dystrophy” is the broad name for your condition, your experience will depend almost entirely on which subtype you have. Each subtype is caused by a different genetic “glitch” and results in a unique type of deposit in a specific layer of your cornea [1][2].

1. Fuchs’ Endothelial Corneal Dystrophy (FECD)

Fuchs’ (pronounced “fooks”) is the most common subtype and affects the endothelium, the innermost “pump” layer of the cornea [3].

  • The Cause: Most cases are linked to the TCF4 gene, where a repeating section of DNA expands and becomes toxic to the pump cells [4][5].
  • The Change: Tiny bumps called guttae form on the back of the cornea [6]. As the pump cells die, the cornea swells with fluid (edema) [7].
  • Behavior: Vision is typically worst in the morning and clears up as the day goes on [8]. It is a late-onset condition, usually showing up after age 40 [6].

2. Lattice Corneal Dystrophy (LCD)

Lattice dystrophy affects the stroma, the thick middle layer of the cornea.

  • The Cause: It is caused by mutations in the TGFBI gene, which makes a protein called keratoepithelin [9].
  • The Change: The mutated protein forms clear, branching “threads” called amyloid that look like a lattice or a spiderweb under a microscope [10][11].
  • Behavior: It often causes recurrent corneal erosions—sudden, painful scratches on the surface of the eye—starting as early as the teenage years [12].

3. Granular Corneal Dystrophy (GCD)

Granular dystrophy also affects the stroma and is caused by different mutations on the same TGFBI gene as Lattice [9].

  • The Change: It creates white, crumb-like deposits (hyaline) that look like “breadcrumbs” or “snowflakes” in the center of the cornea [13][14].
  • Behavior: Vision stays clear for a long time because the areas between the “crumbs” remain transparent [15]. However, over decades, the crumbs can multiply and create a diffuse haze [15].

4. Macular Corneal Dystrophy (MCD)

Although less common than the others, Macular Dystrophy is often more aggressive.

  • The Cause: It is caused by a mutation in the CHST6 gene, which interferes with how the eye processes certain sugars (glycosaminoglycans) [16][17].
  • The Inheritance: Unlike most other dystrophies which are autosomal dominant, Macular is autosomal recessive. This means that both parents must pass down the mutated gene for a child to develop the disease [17].
  • The Change: Unlike the “crumbs” of Granular, this creates a gray-white diffuse haze that spreads across the entire cornea, from edge to edge [12].
  • Behavior: Vision loss usually starts earlier (often in childhood or the 20s) and is more severe because the haze is not limited to the center [12][16].

Why Subtype Matters for Treatment

Understanding your specific subtype is essential because the surgical approach varies:

  • For Fuchs’: Surgeons often only replace the thin inner pump layer (procedures called DMEK or DSAEK) [18][19].
  • For Lattice and Granular: Surgeons may use DALK, which replaces the front and middle layers while keeping your own healthy inner layer [20].
  • For Macular: Depending on how deep the haze goes, a full-thickness transplant (Penetrating Keratoplasty) might be needed, although partial-thickness (DALK) is used if the deepest layers are unaffected [21][22].

Summary Table of Subtypes

Subtype Primary Gene Inheritance Typical Deposit Primary Layer
Fuchs’ (FECD) TCF4 Autosomal Dominant Guttae (Matrix) Endothelium [6]
Lattice (LCD) TGFBI Autosomal Dominant Amyloid (Lines) Stroma [10]
Granular (GCD) TGFBI Autosomal Dominant Hyaline (Crumbs) Stroma [14]
Macular (MCD) CHST6 Autosomal Recessive Glycosaminoglycans Stroma (often extending to other layers) [16]

Frequently Asked Questions

What is the difference between Fuchs and Macular corneal dystrophy?
Fuchs typically causes blurry vision in the morning that improves throughout the day and starts later in life. Macular dystrophy often begins in childhood, causing a severe, diffuse haze and blurry vision that lasts all day long.
Why do I wake up with sharp stabbing eye pain?
Sharp, stabbing eye pain upon waking is often caused by recurrent corneal erosions. These are sudden scratches on the surface of the eye, which are a very common symptom for people with Lattice Corneal Dystrophy.
Are corneal dystrophies inherited from parents?
Yes, most corneal dystrophies are passed down through families. Subtypes like Fuchs, Lattice, and Granular are usually autosomal dominant, meaning you only need one copy of the mutated gene. Macular dystrophy requires both parents to pass down the gene.
Does the type of corneal dystrophy I have change my surgery options?
Yes, surgery depends entirely on which layer of your cornea is affected by your subtype. For example, Fuchs primarily needs an inner-layer transplant, while Lattice or Granular may require replacing the front and middle layers of the cornea.
Will my children get my corneal dystrophy?
The risk depends on your specific subtype and how it is inherited. You should ask your eye doctor about screening recommendations and the age your family members should be checked based on your exact genetic diagnosis.

Questions for Your Doctor

  • • Based on my imaging, am I seeing the 'breadcrumb' deposits of Granular Dystrophy or the 'lattice lines' of Lattice Dystrophy?
  • • Does my Fuchs' diagnosis involve the TCF4 gene expansion, and does that change my expected progression?
  • • Since Macular Dystrophy can affect the endothelium, should we be monitoring my endothelial cell count?
  • • Given my specific subtype, what is the 'recurrence rate' if I eventually need a corneal transplant?
  • • Are my siblings or children at high risk for the same subtype, and at what age should they be screened based on our family's inheritance pattern?

Questions for You

  • • Do I notice my vision is cloudiest in the morning (common in Fuchs) or generally blurry all day (common in Macular)?
  • • Have I experienced sharp 'stabbing' pains in my eye upon waking up, which might indicate recurrent erosions?
  • • Have I had any previous eye surgeries, like LASIK, that seemed to make my vision worse instead of better?
  • • Is anyone else in my family using special eye drops or wearing thick glasses for similar 'cloudy' vision?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [The latest IC3D classification of corneal dystrophies-Overview and changes of the 3rd edition].

    Berger T, Weiss JS, Lisch W, Seitz B

    Die Ophthalmologie 2024; (121(9)):714-725 doi:10.1007/s00347-024-02066-w.

    PMID: 38951244
  2. 2

    Genotype-Phenotype Correlations in Corneal Dystrophies: Advances in Molecular Genetics and Therapeutic Insights.

    Liskova P, Skalicka P, Dudakova L, Vincent AL

    Clinical & experimental ophthalmology 2025; (53(3)):232-245 doi:10.1111/ceo.14516.

    PMID: 40079222
  3. 3

    Practice patterns of corneal transplantation in Europe: first report by the European Cornea and Cell Transplantation Registry.

    Dunker SL, Armitage WJ, Armitage M, et al.

    Journal of cataract and refractive surgery 2021; (47(7)):865-869 doi:10.1097/j.jcrs.0000000000000574.

    PMID: 33577274
  4. 4

    Biallelic excision of the CTG18.1 expansion in two Fuchs endothelial corneal dystrophy-derived iPSC lines and one control (SCTCi046-A-1, SCTCi047-A-1 and SCTCi041-A-1) using an episomal vector-based CRISPR/Cas9 approach.

    Landi E, Zondag R, Dehnen JA, et al.

    Stem cell research 2025; (89()):103881 doi:10.1016/j.scr.2025.103881.

    PMID: 41344296
  5. 5

    Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity.

    Zarouchlioti C, Sanchez-Pintado B, Hafford Tear NJ, et al.

    American journal of human genetics 2018; (102(4)):528-539 doi:10.1016/j.ajhg.2018.02.010.

    PMID: 29526280
  6. 6

    Fuchs endothelial corneal dystrophy: an updated review.

    Altamirano F, Ortiz-Morales G, O'Connor-Cordova MA, et al.

    International ophthalmology 2024; (44(1)):61 doi:10.1007/s10792-024-02994-1.

    PMID: 38345780
  7. 7

    Evaluation of Visual Quality in Patients With Fuchs Endothelial Corneal Dystrophy.

    Oie Y, Watanabe S, Nishida K

    Cornea 2016; (35 Suppl 1()):S55-S58 doi:10.1097/ICO.0000000000000994.

    PMID: 27631348
  8. 8

    Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies.

    Malhotra D, Casey JR

    Reviews of physiology, biochemistry and pharmacology 2020; (178()):41-81 doi:10.1007/112_2020_39.

    PMID: 32789790
  9. 9

    Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies.

    Nielsen NS, Poulsen ET, Lukassen MV, et al.

    Progress in retinal and eye research 2020; (77()):100843 doi:10.1016/j.preteyeres.2020.100843.

    PMID: 32004730
  10. 10

    Anterior Segment Optical Coherence Tomography in the Diagnosis of Corneal Stromal Dystrophies in Romania.

    Gheorghe AG, Arghirescu AM, Voinea LM, et al.

    Maedica 2025; (20(4)):833-839 doi:10.26574/maedica.2025.20.4.833.

    PMID: 41537071
  11. 11

    Rare TGFBI Mutation c.1553T>G p.(L518R) in Lattice Corneal Dystrophy: Comprehensive Clinical and Genetic Analysis in a Chinese Family.

    Cui X, Shu L, Liu B, et al.

    American journal of ophthalmology 2025; (279()):127-136 doi:10.1016/j.ajo.2025.07.012.

    PMID: 40669590
  12. 12

    Detailed corneal and genetic characteristics of a pediatric patient with macular corneal dystrophy - case report.

    Nowińska A, Chlasta-Twardzik E, Dembski M, et al.

    BMC ophthalmology 2021; (21(1)):285 doi:10.1186/s12886-021-02041-y.

    PMID: 34301210
  13. 13

    Mini-Review: Clinical Features and Management of Granular Corneal Dystrophy Type 2.

    Chang MS, Jun I, Kim EK

    Korean journal of ophthalmology : KJO 2023; (37(4)):340-347 doi:10.3341/kjo.2023.0032.

    PMID: 37336511
  14. 14

    Concordance Between Clinical and Pathological Diagnosis of Stromal Corneal Dystrophies in a Large Case Series.

    Fajardo A, Jara Noel K, Azevedo A, et al.

    Cornea 2025; (44(12)):1528-1531 doi:10.1097/ICO.0000000000003980.

    PMID: 40938735
  15. 15

    Association Between Visual Acuity and the Corneal Area Occupied by Granular Lesions, Linear Lesions, or Diffuse Haze in Patients With Granular Corneal Dystrophy Type 2.

    Kim HS, Rim TH, Kim TI, Kim EK

    Cornea 2018; (37(5)):542-547 doi:10.1097/ICO.0000000000001540.

    PMID: 29443809
  16. 16

    Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish.

    Basol M, Ersoz-Gulseven E, Ozaktas H, et al.

    The FEBS journal 2025; (292(2)):373-390 doi:10.1111/febs.17337.

    PMID: 39642091
  17. 17

    Novel compound heterozygous mutations in the CHST6 gene cause macular corneal dystrophy in a Han Chinese family.

    Huang Y, Yuan L, Cao Y, et al.

    Annals of translational medicine 2021; (9(8)):622 doi:10.21037/atm-20-7178.

    PMID: 33987320
  18. 18

    Fuchs Dystrophy and Cataract: Diagnosis, Evaluation and Treatment.

    Ali M, Cho K, Srikumaran D

    Ophthalmology and therapy 2023; (12(2)):691-704 doi:10.1007/s40123-022-00637-1.

    PMID: 36637659
  19. 19

    Therapeutic future of Fuchs endothelial corneal dystrophy: An ongoing way to explore.

    Liu JX, Chiang TL, Hung KF, Sun YC

    Taiwan journal of ophthalmology 2024; (14(1)):15-26 doi:10.4103/tjo.TJO-D-23-00115.

    PMID: 38654984
  20. 20

    Deep anterior lamellar keratoplasty and penetrating keratoplasty in macular corneal dystrophy: comparison of visual and topographic outcomes and complications.

    Balıkçı AT, Burcu A, Akkaya ZY, et al.

    Arquivos brasileiros de oftalmologia 2024; (87(3)):e20230109 doi:10.5935/0004-2749.2023-0109.

    PMID: 38537050
  21. 21

    The role of corneal endothelium in macular corneal dystrophy development and recurrence.

    Zhang BN, Qi B, Dong C, et al.

    Science China. Life sciences 2024; (67(2)):332-344 doi:10.1007/s11427-023-2364-3.

    PMID: 37480470
  22. 22

    Efficacy and Safety of Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty in Corneal Macular Dystrophy: A Systematic Review and Meta-Analysis.

    Awad AA, Elettreby AM, Abo Elnaga AA, et al.

    Journal of ophthalmology 2025; (2025()):8867750 doi:10.1155/joph/8867750.

    PMID: 40809355

This page provides educational information about corneal dystrophy subtypes. It does not replace professional medical advice from your ophthalmologist regarding your specific diagnosis or treatment plan.

Stay up to date

Get notified when new research about Corneal dystrophy is published.

No spam. Unsubscribe anytime.